Acarbose
آکاربوز
🍽️ Alimentary Tract And MetabolismAlpha-glucosidase inhibitor
Market / country: 🇺🇸 USA
Precose (US) · Glucobay (GB)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Acarbose · Dosage and Administration
- • Maximum: ≤60 kg → 50 mg three times daily; >60 kg → 100 mg three times daily. FDA Acarbose · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Diabetic ketoacidosis; cirrhosis; inflammatory bowel disease, colonic ulceration, partial obstruction; hypersensitivity. FDA Acarbose · Contraindications
Formulations
- 25 mg tablet — tablet 🇺🇸 USA FDA Acarbose · How Supplied
- 50 mg tablet — tablet 🇺🇸 USA FDA Acarbose · How Supplied
- 100 mg tablet — tablet 🇺🇸 USA FDA Acarbose · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Acarbose · PREGNANCY
“Teratogenic Effects: Pregnancy Category B.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Acarbose · Precautions/Warnings – Nursing Mothers
“A small amount of radioactivity has been found in the milk of lactating rats after administration of radiolabeled acarbose.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Acarbose · Precautions/Warnings – Pediatric Use
“Safety and effectiveness of Acarbose Tablets in pediatric patients have not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Acarbose · Precautions/Warnings – Geriatric Use
“No overall differences in safety and effectiveness were observed between these subjects and younger subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA090912
- DailyMed (FDA label)FDA Acarbose
- MedlinePlus (NIH)Acarbose
- WHO ATC/DDDA10BF01
- Darooyab (Iran)Acarbose
🇮🇷 Registered in Iran Darooyab · G-619/Acarbose
Dosage forms with Iranian generic codes, per Darooyab.
- 02015 · ACARBOSE 100MG TAB · قرص آکاربوس ۱۰۰ میلیگرم
- 02016 · ACARBOSE 50MG TAB · قرص آکاربوس ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Acarbose · How SuppliedFDA Acarbose · Dosage and AdministrationFDA Acarbose · ContraindicationsFDA Acarbose · PREGNANCYFDA Acarbose · Precautions/Warnings – Nursing MothersFDA Acarbose · Precautions/Warnings – Pediatric UseFDA Acarbose · Precautions/Warnings – Geriatric UseFDA Acarbose · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-619/Acarbose
- Clinical review⚠ Unverified